Oshen Holdings

Oshen Holdings functions as a family office, strategically deploying capital within the science and technology sectors. The firm’s primary investment focus lies in medtech and biotech, seeking out and funding innovations that align with its commitment to advancing solutions. It emphasizes supporting ventures that offer tangible improvements and address critical needs within these specialized industries.

Established in 2022, Oshen Holdings began its operations with a clear mandate to identify and cultivate promising opportunities. Although specific individual founders of the family office are not publicly detailed, its inception underscores a dedicated approach to funding the future of life sciences and technology. The firm maintains its headquarters in Switzerland, guiding its investment activities from this central location.

The entities Oshen Holdings supports serve as its "customers," receiving essential financial backing and strategic insight. The firm envisions a future where its investments contribute significantly to the development of technologies designed to enhance the quality of life, especially in areas related to "Better Ageing." It remains committed to empowering groundbreaking scientific and technological advancements.